Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Selmaj, K. W.
Right arrow Articles by Raine, C. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Selmaj, K. W.
Right arrow Articles by Raine, C. S.
NEUROLOGY 1995;45:S44-S49
© 1995 American Academy of Neurology

Experimental autoimmune encephalomyelitis

Immunotherapy with anti-tumor necrosis factor antibodies and soluble tumor necrosis factor receptors

Krzysztof W. Selmaj, MD and Cedric S. Raine, PhD, DcS

From the Department of Neurology, Medical Academy of Lodz, Poland (Dr. Selmaj), and the Department of Pathology, Albert Einstein College of Medicine, Bronx, N.Y. (Drs. Selmaj and Raine).
Address correspondence and reprint requests to Professor K. Selmaj, Department of Neurology, Medical Academy of Lodz, 22 Kopcinskiego Street, 90-153 Lodz, Poland.

Multiple sclerosis (MS) is a demyelinating disease in which an inflammatory cell infiltrate represents a characteristic pathologic feature of active lesions within the CNS.The possibility has been raised that cell-mediated immune mechanisms orchestrate the pathogenesis of MS. Cytokines play a particularly important role in cellular immune mechanisms. These soluble glycoproteins, nonimmunoglobulin in nature, act nonenzymatically to regulate immune cell function. A unique family of cytokines, the tumor necrosis factors (TNFs), demonstrate immunoregulatory activity but are also involved in the effector arm of cellular immune responses. Recently, studies both in vitro and in vivo have suggested a role for TNFs in the pathology of MS. This report summarizes data implicating TNFs in the mechanisms of MS and attempts to apply the anti-TNF approach in the future therapeutic strategy for this disease.

NEUROLOGY 1995;45(Suppl 6): S44-S49






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by AAN Enterprises, Inc.